196 related articles for article (PubMed ID: 34296300)
1. [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer
Pan Y; Zhang L; Zhang X; Liu R
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296300
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
Yang Q; Zhang S; Kang M; Dong R; Zhao J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278510
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] Additive effects of eukaryotic co‑expression plasmid carrying GRIM‑19 and LKB1 genes on breast cancer
Zhang W; Shao Y; Du Y; Geng W; Jiang T; Liu H; Zhang D
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132376
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] MicroRNA‑128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
Wu L; Shi B; Huang K; Fan G
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278481
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
Pang X; Huang K; Zhang Q; Zhang Y; Niu J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132377
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
Wen C; Liu X; Ma H; Zhang W; Li H
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080656
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] Synthetic miR‑145 mimic inhibits multiple myeloma cell growth
Zhang Q; Yan W; Bai Y; Xu H; Fu C; Zheng W; Zhu Y; Ma J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184081
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841439
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195847
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] Function of miR‑212 as a tumor suppressor in thyroid cancer by targeting SIRT1.
Li D; Bai L; Wang T; Xie Q; Chen M; Fu Y; Wen Q
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34435654
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] miR‑200b inhibits migration and invasion in non‑small cell lung cancer cells via targeting FSCN1.
Xiao P; Liu W; Zhou H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132372
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] Knockdown of AQP1 inhibits growth and invasion of human ovarian cancer cells.
Wang Y; Fan Y; Zheng C; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676877
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
Dong S; Jin M; Li Y; Ren P; Liu J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318908
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] Small interfering RNA‑induced silencing of galectin‑3 inhibits the malignant phenotypes of osteosarcoma
Lei P; He H; Hu Y; Liao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296294
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Qu Y; Xia P; Zhang S; Pan S; Zhao J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] Knockdown of CREB1 inhibits tumor growth of human gastric cancer
Rao M; Zhu Y; Cong X; Li Q
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617576
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]